Cellectar Biosciences, Inc. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Cellectar Biosciences, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q1 2024.
  • Cellectar Biosciences, Inc. Common Stock, Shares Authorized for the quarter ending March 31, 2024 was 170M shares, a 6.25% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 170M +10M +6.25% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 170M 0 0% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 160M 0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 160M 0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 160M 0 0% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 170M +10M +6.25% Dec 31, 2022 10-K 2024-03-27
Q3 2022 160M 0 0% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 160M 0 0% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 160M 0 0% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 160M +80M +100% Dec 31, 2021 10-K 2023-03-09
Q3 2021 160M +80M +100% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 160M +80M +100% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 160M +80M +100% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 80M 0 0% Dec 31, 2020 10-K 2022-03-21
Q3 2020 80M 0 0% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 80M 0 0% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 80M 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 80M 0 0% Dec 31, 2019 10-K 2021-03-02
Q3 2019 80M 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 80M 0 0% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 80M 0 0% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 80M 0 0% Dec 31, 2018 10-K 2020-03-09
Q3 2018 80M 0 0% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 80M 0 0% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 80M +40M +100% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 80M +40M +100% Dec 31, 2017 10-K 2019-02-26
Q3 2017 80M +40M +100% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 80M +40M +100% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 40M 0 0% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 40M 0 0% Dec 31, 2016 10-K 2018-03-21
Q3 2016 40M 0 0% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 40M 0 0% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 40M +20M +100% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 40M 0 0% Dec 31, 2015 10-K 2017-03-15
Q3 2015 40M +20M +100% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 40M +20M +100% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 20M -130M -86.7% Mar 31, 2015 10-Q 2015-05-20
Q4 2014 40M +20M +100% Dec 31, 2014 10-K/A 2016-10-20
Q3 2014 20M -130M -86.7% Sep 30, 2014 10-Q/A 2015-05-20
Q2 2014 20M -130M -86.7% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 150M 0 0% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 20M -130M -86.7% Dec 31, 2013 10-K/A 2015-05-20
Q3 2013 150M 0 0% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 150M 0 0% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 150M 0 0% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 150M 0 0% Dec 31, 2012 10-K 2014-03-19
Q3 2012 150M 0 0% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 150M 0 0% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 150M Mar 31, 2012 10-Q 2012-05-04
Q4 2011 150M 0 0% Dec 31, 2011 10-K 2013-03-28
Q3 2011 150M Sep 30, 2011 10-Q 2011-11-07
Q2 2011 150M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 150M Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.